Delivery Order SPE2DB22D3016-SPE2DB25FANC9
Award Date
2/12/25
Potential Completion Date
3/6/25
Potential Value
$103K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,547.90 firm fixed-price contract is for the delivery of 200-unit vials of Botox, a prescription medication. The contract has an ultimate completion date of March 4, 2025 and was awarded on February 10, 2025. The place of performance is Conshohocken, Pennsylvania. This delivery order is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $58,213.00 firm fixed-price contract is for the delivery of BOTOX 200 unit vials. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of Botox, a specialty medication, with a ceiling value of $1,204.50 and a completion date of December 27, 2024. The contract is a firm-fixed-price, delivery order contract type and was not set aside for a specific business category. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of Botox. The contract is a firm-fixed-price delivery order with a ceiling value of $13,971.12 and an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $27,942.24 firm fixed price contract is for the delivery of 200 unit vials of BOTOX to be completed by April 19, 2024. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that serves as the primary vehicle for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $61,123.65 firm-fixed-price contract is for the delivery of 200-unit vials of Botox to support federal healthcare programs. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $50,645.31 firm fixed price contract is for the delivery of Botox 200 unit vials, a specialty pharmaceutical product. The contract has a completion date of September 12, 2024 and was awarded on August 21, 2024. No set-aside designation was used. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by DLA and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 200-unit vials of the drug Botox, with a ceiling value of $22,224.54 and a completion date of February 27, 2025. The contract is a firm fixed-price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,985.56, is for the delivery of 200-unit vials of the drug Botox. The award date is March 1, 2024, and the ultimate completion date is March 22, 2024. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,838.32 firm fixed-price contract is for the supply of BOTOX 200 unit vials, with a period of performance through January 21, 2025. The contract is not designated as a set-aside. It appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...